Drug Profile
Delta-8-THC
Alternative Names: Delta-8-tetrahydrocannabinolLatest Information Update: 27 Jul 1999
Price :
$50
*
At a glance
- Originator Unknown
- Developer Yissum Research Development Company
- Class Antiemetics; Cannabinoids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Nausea and vomiting
Most Recent Events
- 27 Jul 1999 No-Development-Reported for Emesis in Israel (PO)
- 20 Feb 1997 New profile
- 20 Feb 1997 Investigation in Emesis in Israel (PO)